Steven D. Harr

2023 - Sana Biotechnology

In 2023, Steven D. Harr earned a total compensation of $2.7M as President, Chief Executive Officer, and Director at Sana Biotechnology, a 30% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$377,001
Option Awards$1,631,250
Salary$659,411
Other$4,000
Total$2,671,662

Harr received $1.6M in option awards, accounting for 61% of the total pay in 2023.

Harr also received $377K in non-equity incentive plan, $659.4K in salary and $4K in other compensation.

Rankings

In 2023, Steven D. Harr's compensation ranked 358th out of 2,983 executives tracked by ExecPay. In other words, Harr earned more than 88.0% of executives.

ClassificationRankingPercentile
All
358
out of 2,983
88th
Division
Manufacturing
206
out of 1,637
87th
Major group
Chemicals And Allied Products
142
out of 906
84th
Industry group
Drugs
139
out of 869
84th
Industry
Biological Products, Except Diagnostic Substances
50
out of 211
76th
Source: SEC filing on April 26, 2024.

Harr's colleagues

We found two more compensation records of executives who worked with Steven D. Harr at Sana Biotechnology in 2023.

2023

Douglas Williams

Sana Biotechnology

Former Executive Vice President and President, Research and Development

2023

Nathan Hardy

Sana Biotechnology

Chief Financial Officer

News

In-depth

You may also like